For experiments 2–5 and FMT, the baseline parameters were kept the same as for Gopalakrishnan et al. 14 (Fig. 2C and Supplementary Table S3) because both of these experiments involved the same cell line (BP melanoma) and the same treatment (anti-PD-L1). Here, CD274 is linked to melanoma.